Ein Arzt berät einen Patienten (Symbolbild).
Dienstag, 08.12.2015 23:00 von | Aufrufe: 103

WeissLaw LLP: Wilshire Bancorp, Inc.'s Board May Not Be Acting In The Best Interests of WIBC Shareholders

Ein Arzt berät einen Patienten (Symbolbild). © TommL / Vetta / Getty Images https://www.gettyimages.de/

PR Newswire

NEW YORK, Dec. 8, 2015 /PRNewswire/ -- The proposed merger of Wilshire Bancorp, Inc. ("WIBC" or the "Company") and BBCN Bancorp, Inc. ("BBCN") is being investigated by WeissLaw LLP for possible breaches of fiduciary duty and other violations of law by the Board of Directors of WIBC.  On December 7, 2015, the Company announced the signing of a definitive agreement to merge with BBCN in a stock-for-stock transaction valued at approximately $1.0 billion.  Under the terms of the agreement, shareholders of WIBC will receive 0.7034 of a share BBCN for each WIBC share they own; representing a consideration of $13.00 per WIBC share, based on the December 4 closing price of BBCN.

WeissLaw is investigating whether WIBC's Board acted to maximize shareholder value prior to entering into the agreement.  Notably, the offer price represents a mere 9.4 % premium over WIBC's December 4 trading price of $11.88.  Additionally, at least one analyst set a target price of $15.50 per share, or $2.50 above the offer price.   

Given these facts, WeissLaw is investigating the Board of Directors' decision to sell WIBC and whether WIBC shareholders will obtain their fair proportionate share of the Company's continued success and future growth prospects.  If you own WIBC shares and would like more information about your rights or our investigation, please contact Joshua Rubin either by telephone at (888) 593-4771 or by email at stockinfo@weisslawllp.com

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com or fill out the form on our website, http://www.weisslawllp.com/contact/report_fraud/.

 

SOURCE WeissLaw LLP


ARIVA.DE Börsen-Geflüster

Kurse

Werbung

Mehr Nachrichten zur WILSHIRE BANCORP Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News